Shuttle Pharmaceuticals Holdings, Inc. Profile Avatar - Palmy Investing

Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropi…

Drug Manufacturers - Specialty & Generic
US, Rockville [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of SHPH's Analysis
CIK: 1757499 CUSIP: 825693203 ISIN: US8256932034 LEI: - UEI: -
Secondary Listings
SHPH has no secondary listings inside our databases.